424 related articles for article (PubMed ID: 31526594)
1. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
Fairley JL; Oon S; Saracino AM; Nikpour M
Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
[TBL] [Abstract][Full Text] [Related]
2. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
[TBL] [Abstract][Full Text] [Related]
3. Biological therapies in the treatment of cutaneous lupus erythematosus.
Presto JK; Hejazi EZ; Werth VP
Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
[TBL] [Abstract][Full Text] [Related]
4. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G; Helm LA; Clebak KT; Helm M
FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
[TBL] [Abstract][Full Text] [Related]
6. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
Papachristos DA; Oon S; Hanly JG; Nikpour M
Semin Arthritis Rheum; 2021 Feb; 51(1):49-71. PubMed ID: 33360230
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Lupus Erythematosus in Children.
Tsang V; Leung AKC; Lam JM
Curr Pediatr Rev; 2021; 17(2):103-110. PubMed ID: 33655840
[TBL] [Abstract][Full Text] [Related]
9. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
Rosen JD; Paul S; Maderal A
Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous lupus.
Chang AY; Werth VP
Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
12. Review of treatment for discoid lupus erythematosus.
Garza-Mayers AC; McClurkin M; Smith GP
Dermatol Ther; 2016 Jul; 29(4):274-83. PubMed ID: 27073142
[TBL] [Abstract][Full Text] [Related]
13. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
Tzellos TG; Kouvelas D
Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupus erythematosus: diagnosis and management.
Fabbri P; Cardinali C; Giomi B; Caproni M
Am J Clin Dermatol; 2003; 4(7):449-65. PubMed ID: 12814335
[TBL] [Abstract][Full Text] [Related]
15. Recent Insight on the Management of Lupus Erythematosus Alopecia.
Desai K; Miteva M
Clin Cosmet Investig Dermatol; 2021; 14():333-347. PubMed ID: 33833540
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment: A Narrative Review of Literature for Clinical Practice.
Yuki EFN; Silva CA; Aikawa NE; Romiti R; Heise CO; Bonfa E; Pasoto SG
J Clin Rheumatol; 2021 Sep; 27(6):248-259. PubMed ID: 31693649
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous lupus erythematosus: update of therapeutic options part I.
Kuhn A; Ruland V; Bonsmann G
J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis.
Chasset F; Bouaziz JD; Costedoat-Chalumeau N; Francès C; Arnaud L
Br J Dermatol; 2017 Jul; 177(1):188-196. PubMed ID: 28112801
[TBL] [Abstract][Full Text] [Related]
20. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
